Clinical Study

Ecog Multiple Myeloma Equate Trial (Eaa181)

Posted Date: Apr 20, 2021

  • Investigator: Bryan Hambley
  • Specialties:
  • Type of Study: Drug

A randomized, phase 3 trial for newly diagnosed multiple myeloma comparing induction regimens in patients not planned for early autologous transplant.

Criteria:

Newly Diagnosed Adults With Multiple Myeloma.

Keywords:

Myeloma, Daratumumab, Mrd

For More Information:

Bryan Hambley
5138544268
hamblebc@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.